CRS has a uniquely diverse and innovative membership working in industry, academia, and government. Join us!
Robert S. LangerMassachusetts Institute of Technology
Henry BremJohn Hopkins University
Amar SawhneyOcular Therapeutix, INC.
Paula T. HammondKoch Institute MIT
Featured Content from the Newsletter
Nanocarrier System for Oral Anticancer Drug Delivery Using Styrene Maleic Acid MicellesSignificant limiting factors are associated with the oral administration of anticancer drugs, such as their low bioavailability and local toxicity to the GI tract. The encapsulation of these anticancer drugs into a nanomicelle carrier should decrease the toxicity to the GI tract. Also, nanosized formulations can selectively accumulate in the tumor tissue, in turn improving the therapeutic efficacy and safety of these drugs. Poly(styrene-co-maleic acid) micelles were synthesized and loaded with epirubicin in this study of oral uptake and transport.
CRS Vision Statement:Visionary leadership in delivery science and technology. CRS Mission Statement:CRS is an international, multidisciplinary society dedicated to delivery science and technology.